Hughes & Company Closes Second Private Equity Fund
Hughes & Company, a private equity firm specializing in healthcare software and tech-enabled services, has successfully closed its second private equity fund at an impressive $260 million. This amount surpasses the original target of $200 million, showcasing the strong support and trust from investors.
Commitment to Growth and Innovation
"We are deeply grateful for the confidence shown by our existing investors and our new partners who joined Fund II," said Travis Hughes, the Managing Partner and Founder of Hughes & Company. He emphasized the responsibility associated with their investors' commitment and their long-term focus on enhancing the healthcare system.
Over the last 15 years, Hughes & Company has aimed to grow companies that contribute positively to healthcare, revealing a vast landscape of opportunities still ahead. The firm is dedicated to its investors as well as the leadership teams of its portfolio companies, striving to develop businesses that not only reduce costs but also improve operational efficiencies.
Expertise and Team Expansion
The investment team at Hughes & Company consists of seasoned professionals well-versed in the healthcare industry's intricacies. They possess a knack for generating significant value and are pivotal to the firm's success.
Naile Kovuk, another Managing Partner, stated, "To keep delivering strong results, we must invest in more than just companies; we need to invest in our team and culture." She recognized the ongoing expansion of their capabilities, which enhances their ability to partner effectively with management teams to foster enduring value creation.
Successful Track Record and Future Endeavors
Founded in 2010, Hughes & Company boasts a noteworthy history of investing in healthcare-oriented software and services. Their first fund, Hughes Growth Equity Fund I, L.P., closed in 2021 at $116 million, supporting various growth-stage companies.
A significant highlight of their investment journey is the recent sale of Azara Healthcare, a population health management software provider, to Insight Partners, underscoring the firm's effective investment strategies.
The firm has recently initiated its first investment from Fund II through the merger of Curvo and BroadJump. This collaboration creates a consolidated spend management and analytics platform aimed at enhancing efficiency for hospitals and health systems. The newly formed entity promises a comprehensive suite of tools focused on cost reduction and improved healthcare outcomes.
About Hughes & Company
Hughes & Company is committed to driving growth and innovation within the healthcare sector, specializing in software and technology-enabled services. With a focus on forming strategic partnerships, the firm provides essential capital and guidance to accelerate the scalability of solutions that enhance patient outcomes and operational performance.
For More Information
For further details, please contact John Gonda at 616-309-4888.
Frequently Asked Questions
What is the purpose of the Hughes Growth Equity Fund II?
The fund focuses on investing in healthcare software and technology-enabled services to drive growth and innovation.
How much did Hughes & Company raise for Fund II?
Hughes & Company successfully raised $260 million for the second private equity fund, exceeding its original target of $200 million.
What distinguishes the investment team at Hughes & Company?
The investment team comprises healthcare industry experts and thought leaders with proven success in creating substantial value in their investments.
What was the outcome of the first fund?
The first fund, Hughes Growth Equity Fund I, L.P., closed at $116 million and supported multiple growth-stage companies, including the successful exit through the sale of Azara Healthcare.
What is the significance of the merger between Curvo and BroadJump?
The merger aims to provide a unified spend management and analytics platform, enhancing efficiency and cost reduction for healthcare organizations.
